“Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: A 6-year retrospective study” (2018) Biomolecules and Biomedicine, 18(4), pp. 361–366. doi:10.17305/bjbms.2018.3544.